108 related articles for article (PubMed ID: 3218759)
1. Electrochemical study of the hallucinogen (+-)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane.
Richter P; Morales A; Gómez-Jeria JS; Morales-Lagos D
Analyst; 1988 Jun; 113(6):859-63. PubMed ID: 3218759
[No Abstract] [Full Text] [Related]
2. 4-Bromo-2,5-dimethoxyphenethylamine: identification of a new street drug.
Ragan FA; Hite SA; Samuels MS; Garey RE
J Anal Toxicol; 1985; 9(2):91-3. PubMed ID: 3990254
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
Shimamine M; Takahashi K; Nakahara Y
Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
[TBL] [Abstract][Full Text] [Related]
4. A death due to 4-bromo-2,5-dimethoxyamphetamine.
Winek CL; Collom WD; Bricker JD
Clin Toxicol; 1981 Mar; 18(3):267-71. PubMed ID: 7237958
[No Abstract] [Full Text] [Related]
5. Identification and quantitation of 4-bromo-2,5-dimethoxyamphetamine in seized blotters.
Burrai L; Nieddu M; Palomba M; Pirisi MA
Leg Med (Tokyo); 2015 Jan; 17(1):56-9. PubMed ID: 25248801
[TBL] [Abstract][Full Text] [Related]
6. Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.
Oberlender RA; Kothari PJ; Nichols DE; Zabik JE
J Med Chem; 1984 Jun; 27(6):788-92. PubMed ID: 6737421
[TBL] [Abstract][Full Text] [Related]
7. Studies on radioimmunoassay for 2,5-dimethoxy-4-methylamphetamine.
Nagamatsu K; Kido Y; Urakabo G
Chem Pharm Bull (Tokyo); 1977 Dec; 25(12):3390-4. PubMed ID: 564751
[No Abstract] [Full Text] [Related]
8. Bromo-DMA: the Australasian hallucinogen?
Buhrich N; Morris G; Cook G
Aust N Z J Psychiatry; 1983 Sep; 17(3):275-9. PubMed ID: 6580896
[TBL] [Abstract][Full Text] [Related]
9. Direct quantitative analysis of lysergic acid diethylamide (LSD) and 2, 5-dimethoxy-4-methylamphetamine (STP) on thin-layer chromatograms.
Niwaguchi T; Inoue T
J Chromatogr; 1976 Jun; 121(1):165-9. PubMed ID: 932131
[No Abstract] [Full Text] [Related]
10. [Determination of 4-bromo-2,5-dimethoxyamphetamine (DOB) found in illicit tablets seized in Italy].
Furnari C; Ottaviano V; Rosati F
Ann Ist Super Sanita; 2001; 37(2):297-300. PubMed ID: 11758288
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
12. Conformational energy differences between side chain alkylated analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Weintraub HJ; Nichols DE; Makriyannis A; Fesik SW
J Med Chem; 1980 Mar; 23(3):339-41. PubMed ID: 7365752
[TBL] [Abstract][Full Text] [Related]
13. 4-bromo-2,5-dimethoxyamphetamine: psychoactivity, toxic effects and analytical methods.
Delliou D
Forensic Sci Int; 1983; 21(3):259-67. PubMed ID: 6873782
[TBL] [Abstract][Full Text] [Related]
14. Identification of 2-,3-, and 4-methoxyamphetamines and 2-,3-, and 4-methylamphetamines.
Bailey K; Beckstead HD; Legault D; Verner D
J Assoc Off Anal Chem; 1974 Sep; 57(5):1134-43. PubMed ID: 4413770
[No Abstract] [Full Text] [Related]
15. Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose.
Balíková M
Forensic Sci Int; 2005 Oct; 153(1):85-91. PubMed ID: 15979834
[TBL] [Abstract][Full Text] [Related]
16. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
17. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
Jacob JN; Nichols DE
J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
[TBL] [Abstract][Full Text] [Related]
18. Use of high pressure liquid chromatography for the separation of drugs of abuse.
Chan ML; Whetsell C; McChesney JD
J Chromatogr Sci; 1974 Sep; 12(9):512-6. PubMed ID: 4472421
[No Abstract] [Full Text] [Related]
19. Radioimmunoassays of 3,4,5-trimethoxyphenethylamine (mescaline) and 2,5-dimethoxy-4-methylphenyl-isopropylamine(DOM).
Riceberg LJ; Van Vunakis H; Levine L
Anal Biochem; 1974 Aug; 60(2):551-9. PubMed ID: 4210779
[No Abstract] [Full Text] [Related]
20. Bromo-DMA: new hallucinogenic drug.
Delliou D
Med J Aust; 1980 Jan; 1(2):83. PubMed ID: 7360100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
